Optieum Biotechnologies
PrivateLast Round
Grant
Mar 18, 2025
Total Funding Raised
$11.09M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Optieum Biotechnologies is a biotechnology company that develops antibody-based therapies intended to treat cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Optieum Biotechnologies Comparables
Compare Optieum Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noile-Immune Biotech | 84% | |
| Autolus | 70% | |
| ProMab Biotechnologies | 65% |
Optieum Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 18, 2025 | ||||
| Series A | Jan 14, 2025 | ||||
| Grant | Jan 27, 2022 | ||||
| Seed | Sep 30, 2021 |
Key People
Founding team and executive leadership
Optieum Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| Saisei Ventures | Series A |
| Kobe University Capital | Series A |
| Keio Innovation Initiative | Series A |
| Iyogin Capital Company Limited | Series A, Seed |
| New Energy and Industrial Technology Development Organization | Grant |
| ANRI株式会社 | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 214% MoM, from 402 to 1.3K.
- Jul 17, 2026
Grew 21% QoQ, from 14 to 17 employees.
Optieum Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Optieum Biotechnologies's valuation, stock price, and market status.
Is Optieum Biotechnologies a public or private company?
Optieum Biotechnologies is a private company.
What is the current stock price of Optieum Biotechnologies?
Optieum Biotechnologies is a private company with no public stock price. No recent secondary market data is available.
How much is Optieum Biotechnologies worth (valuation)?
Valuation information for Optieum Biotechnologies is not publicly available.
Can I buy Optieum Biotechnologies stock?
Optieum Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Optieum Biotechnologies's last funding round?
Optieum Biotechnologies's most recent funding round was Grant on March 18, 2025.
Who are the main investors in Optieum Biotechnologies?
Key investors in Optieum Biotechnologies include Saisei Ventures, ANRI株式会社.
Will Optieum Biotechnologies IPO soon?
No public IPO plans have been announced for Optieum Biotechnologies.
How can I track Optieum Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Optieum Biotechnologies's secondary market activity and sign up for updates.